Teva to Host R&D Day on Wednesday, November 11 in New York CityGlobeNewsWire · Oct 12, 2026
TEVA Gets FDA Nod for Weltruza as Once-Monthly LAI in SchizophreniaZacks Investment Research · Oct 12, 2026
Teva Pharmaceutical Industries Limited (TEVA) Discusses FDA Approval of Weltruza and Strategic Growth Initiatives TranscriptSeeking Alpha · Oct 9, 2026
FDA Approves Teva's New Once-Monthly Schizophrenia InjectionBenzinga · Oct 9, 2026
Teva Wins FDA Approval for Monthly Schizophrenia Injectable WELTRUZAMarketBeat · Oct 9, 2026
Teva wins FDA approval for monthly schizophrenia injection WeltruzaReuters · Oct 9, 2026Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, produces, and sells active pharmaceutical ingredients (APIs).
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 29, 2026 | $0.08 | $0.02 | Miss |
| Apr 29, 2026 | $0.50 | $0.53 | Beat |
| Jan 28, 2026 | $0.65 | $0.96 | Beat |
| Nov 5, 2025 | $0.68 | $0.78 | Beat |
| Jul 30, 2025 | $0.63 | $0.66 | Beat |
| May 7, 2025 | $0.47 | $0.52 | Beat |